SYNJUNIN
Live / Applied — Extension of time to oppose received (as of 16 Mar 2026)
What this means for you
Not registered yet, but its 13 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99495252
- Mark type
- Stylized text
- Filed
- 13 Nov 2025
- Published for opposition
- 17 Feb 2026
- Attorney of record
- Yue (Robert) Xu
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; Biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of hemophilia; Clinical medical reagents for use in gene therapy, gene diagnosis and gene testing
Owner
- Belief BioMed (Shanghai) Co., Ltd., Shanghai, CN
- Belief BioMed (Shanghai) Co., Ltd., Shanghai, CN
Prosecution history
- 16 Mar 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Jan 2026 — ASSIGNED TO EXAMINER
- 13 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 13 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Nov 2025 — NEW APPLICATION ENTERED